Systematic Review
Accepted on 08 Sep 2025
Pharmacogenetics of metamizole-induced agranulocytosis: a systematic review and drug regulation implications
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1624044
Type at least 3 characters
525 articles
Systematic Review
Accepted on 08 Sep 2025
Dental safety of short-term doxycycline use in children under 8 years: A systematic review and metaanalysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1646638
Original Research
Accepted on 08 Sep 2025
Profiles and influencing factors of pulmonary fibrosis associated with biologic and conventional disease-modifying antirheumatic drugs for autoimmune diseases: a disproportionality study based on FAERS and VigiAccess
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1604895
Original Research
Accepted on 08 Sep 2025
Impact of post-admission changes in potentially inappropriate medication use on risk of subsequent hospitalization among nursing home residents
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1655681
Systematic Review
Accepted on 04 Sep 2025
Efficacy and Safety of Aldosterone Synthase Inhibitors for Uncontrolled Hypertension: A Meta-Analysis of Randomized Controlled Trials and Systematic Review
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1664810
- 645 views
Brief Research Report
Published on 02 Sep 2025
Trends in the use of validated claims-based algorithms in Japanese post-marketing database studies
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1642490
- 596 views
Brief Research Report
Accepted on 01 Sep 2025
Single-versus multiple-inhaler triple therapy in patients with COPD in Spain: a retrospective cohort study comparing adherence, persistence, risk of exacerbations and economic outcomes
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1642470
- 654 views
Original Research
Accepted on 01 Sep 2025
Difference in Outcome Event Coverage between Insurance-Based and Hospital-Based Databases: A Methodological Study of Diabetes Drug Use and Cardiovascular Events in Japan
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1642522
- 474 views
Original Research
Published on 01 Sep 2025
Comparative assessment of antibacterial drugs used at the hospital level before and during COVID-19, according to the WHO AWaRe classification
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1642830
- 472 views
Original Research
Accepted on 30 Aug 2025
The Safety and Efficacy of Long-term Use of Calcitonin AnalogsCalcitonin-based Drugs in the Treatment of Osteoporosis in the Elderly: A Pharmacovigilance and RCT Meta-analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1514387
- 1,490 views
Original Research
Published on 29 Aug 2025
High persistence of biologic therapy in patients with Psoriatic arthritis: a real-world evidence from a high-complexity hospital in Colombia
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559168
- 751 views
Opinion
Published on 29 Aug 2025
Is it appropriate to conduct a disproportionality analysis using a spontaneous reporting database to investigate whether drug-related adverse events are dose-dependent?
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563524
- 637 views
Brief Research Report
Published on 29 Aug 2025
Perception of falsified and counterfeit medicines among adults living in Mexico City and the metropolitan area: an underappreciated health risk
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1654822
- 584 views
Mini Review
Published on 26 Aug 2025
Polypharmacy driven synergistic toxicities in elderly breast cancer chemotherapy drug management and adverse drug reactions: a mini review
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1654353
- 765 views
Original Research
Accepted on 25 Aug 2025
Global burden and trends of adverse effects of medical treatment, 1990–2021: an analysis from the global burden of disease study 2021
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1655864
- 401 views
Original Research
Published on 22 Aug 2025
Use of over-the-counter antiallergic products–analysis of sales data in Poland from 2020 to 2023
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1649349
- 812 views